Article

Soluble epoxide hydrolase in Alzheimer’s disease drives neurovascular dysfunction

2025-12-11

Abstract excerpt

Recent advances in anti-amyloid therapies for Alzheimer’s disease have been promising, but they have also highlighted critical challenges, including increased vascular complications, such as amyloid-related imaging abnormalities. Emerging evidence suggests that the soluble epoxide hydrolase may be a promising therapeutic target due to the involvement of sEH-derived diols in inflammation, oxidative stress, and vasc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: efc5d30a-f580-5c27-b9ef-fdc494078e5c
DOI: 10.64898/2025.12.09.692941

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Soluble epoxide hydrolase in Alzheimer’s disease drives neurovascular dysfunctionDOI 10.64898/2025.12.09.692941Read

Inhibition of Soluble Epoxide Hydrolase Rescues Cognitive Deficits by Preserving Neurovascular Integrity and Attenuating Glial- and Neuropathology in Diabetic-Related DementiaSemantic proximity Read

Role of soluble epoxide hydrolase in age-related vascular cognitive decline.Semantic proximity Read

Angiopoietin signalling is a central axis of amyloid-driven vascular dysfunction in Alzheimer’s diseaseSemantic proximity Read

Dual Inhibition of sEH and COX-2 Improved Cognition in Alzheimer’s Disease via Enhanced Myogenic Response and Cerebral Artery DistensibilitySemantic proximity Read

Inhibition of Soluble Epoxide Hydrolase Ameliorates Cerebral Blood Flow Autoregulation and Cognition in Alzheimer’s Disease and Diabetes-Related Dementia Rat ModelsSemantic proximity Read

A proteomic signature of vascular dysfunction linked to tauopathy and degeneration in the aging brainSemantic proximity Read

Shared and disease-specific human brain vascular signatures in Alzheimer’s disease, frontotemporal dementia, and Huntington’s diseaseSemantic proximity Read

C/EBPβ/AEP Signaling Activated by ApoE4 and 27-Hydroxycholesterol in Macrophages Mediates Cerebral Amyloid Angiopathies in Alzheimer’s DiseaseSemantic proximity Read

Soluble epoxide hydrolase: gene structure, expression and deletion.Semantic proximity Read

Dysplasia of cortical capillaries as the origin of Alzheimer’s disease: experimental evidence from APP/PS1Semantic proximity Read

Zonation-dependent single-endothelial cell transcriptomic changes in the aged brainSemantic proximity Read

Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease PatientsSemantic proximity Read